Rickard E Malmström

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. pmc Personalizing health care: feasibility and future implications
    Brian Godman
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    BMC Med 11:179. 2013
  2. ncbi request reprint No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance
    Rickard E Malmström
    Department of Medicine Solna, Clinical Pharmacology Unit, Karolinska University Hospital Solna, SE 171 76 Stockholm, Sweden
    Thromb Haemost 101:157-64. 2009
  3. doi request reprint Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment
    Rickard E Malmström
    Clinical Pharmacology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden
    J Intern Med 266:457-66. 2009
  4. doi request reprint Endothelin attenuates endothelium-dependent platelet inhibition in man
    R E Malmstrom
    Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Acta Physiol (Oxf) 198:441-8. 2010

Collaborators

  • John Pernow
  • Felix Bohm
  • M Settergren
  • Leif Jørgensen
  • Brian Godman
  • Christina Kvalheim
  • Alan Haycox
  • Anna Bucsics
  • Marion Bennie
  • Menno van Woerkom
  • Ken Paterson
  • Raghib Ali
  • Parneet K Cheema
  • Catherine Sermet
  • Sven Äke Lööv
  • Eva Zebedin-Brandl
  • Luka Voncina
  • Durhane Wong-Rieger
  • Steven Simoens
  • Gisbert Selke
  • Andrew Martin
  • Kamila Malinowska
  • Alexander E Finlayson
  • Christoph Baumgärtel
  • Vera Vlahovic-Palcevski
  • Fredrik Nilsson
  • Marija Kalaba
  • Harald Herholz
  • Iñaki Gutierrez-Ibarluzea
  • Ulrich Schwabe
  • Eduardo Diogène
  • Kristina Garuoliene
  • Laura McCullagh
  • Ott Laius
  • Corrine Zara
  • Katharine Harris
  • Elina Asola
  • Stephen Campbell
  • Dominik Tomek
  • Jurij Fürst
  • Miguel Gomes
  • Magdalena Wladysiuk
  • Iain Bishop
  • Krystyna Hviding
  • Saira Jan
  • Lars L Gustafsson
  • Jan Jones
  • Alessandra Ferrario

Detail Information

Publications4

  1. pmc Personalizing health care: feasibility and future implications
    Brian Godman
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    BMC Med 11:179. 2013
    ..Overall, personalized medicine has the potential to revolutionize care. However, current challenges and concerns need to be addressed to enhance its uptake and funding to benefit patients. ..
  2. ncbi request reprint No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance
    Rickard E Malmström
    Department of Medicine Solna, Clinical Pharmacology Unit, Karolinska University Hospital Solna, SE 171 76 Stockholm, Sweden
    Thromb Haemost 101:157-64. 2009
    ....
  3. doi request reprint Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment
    Rickard E Malmström
    Clinical Pharmacology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden
    J Intern Med 266:457-66. 2009
    ..Possible interactions between clopidogrel and atorvastatin, simvastatin or rosuvastatin (a 'non-CYP3A4' metabolized statin) were investigated in a randomized prospective study using sensitive and specific ex vivo platelet function tests...
  4. doi request reprint Endothelin attenuates endothelium-dependent platelet inhibition in man
    R E Malmstrom
    Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Acta Physiol (Oxf) 198:441-8. 2010
    ..Experiments were designed to investigate the effect of ET-1 on endothelium-dependent vasodilatation and attenuation of platelet activation...